Insider Chris Freeman sold shares of Guardant Health during the reporting period, leading to an SEC filing on September 14, 2026.
1 report, 1 independent
Updated Sep 14
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Insider Chris Freeman sold shares of Guardant Health during the reporting period, leading to an SEC filing on September 14, 2026.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Guardant Health
American biotechnology company
Nothing else this week.
-
Chris Freeman
researcher
Nothing else this week.
-
Securities and Exchange Commission
government agency of the Philippines
Related events
- Company disclosed insider trades in an SEC filing on October 22, 2026.
- Insider transactions disclosed in legal filings with the SEC involving Applied Materials.
- Ethan Allen filed an investor presentation with the Securities and Exchange Commission on October 19, 2026.
- A Wealth Management entity filed required reports with the Securities and Exchange Commission on October 22, 2026.
- Avnet disclosed stock acquisitions to the Securities and Exchange Commission on October 18, 2026.